Metabolic disorder patient recruitment

No more recruitment fatigue. With over 20 years of experience, Clariness helps sponsors find, engage, and recruit the right patients for metabolic disorder clinical trials, faster.  

Metabolic disorders hero

The metabolic disorders trial landscape

4,800+

Metabolic disorder trials actively recruiting

9,700+

Study sites seeking patients

3,700+

Clinical trial sponsors​

In a market with 4,800+ clinical trials targeting a limited pool of metabolic disorder patients, Clariness is the right recruitment partner to ensure your study reaches the right patients ahead of your competition.

Reach & recruit the right patients, first.

Fueling metabolic disorder patient recruitment

Metabolic disorder prevalence has more than doubled since 2,000, affecting 31% of women and 26% of men across the globe; but recruitment hasn’t kept pace with the population it needs to reach. 

  • 2x the average SFR due to factors such as complex comorbidities and their layered treatment history 
  • A surge in competition, at the time of writing, 2 sponsors are running 99/142 Phase III obesity studies for the same treatment-naive patients 
  • Studies are designed with lacking insight, for example, ≈50% of the world’s T2D burden sits in China, India, and Southeast Asia, where patient profiles don’t match Western-focused I/E criteria

Clariness has navigated complex global studies for 20+ years, we know how to navigate these barriers to reach your patients. 

Proven results in metabolic disorder recruitment

140+

Global metabolic disorder studies supported

20+

Years of therapeutic expertise

1,000+

Patients randomized globally

Diabetes

Recruiting patients across type 1 & type 2 diabetes studies, with specific treatment histories and protocol requirements.

Obesity

Supporting obesity clinical trials with patient-first recruitment strategies that build trust and improve referral quality.

Metabolic disorders case study

Spotlight: Clariness generated 2,176 referrals via ClinLife® for diabetes type 2 study

Project overview:

  • Patient recruitment for a Phase III diabetes type 2 clinical trial 
  • Across 100 study sites in 10 countries (AU, CA, DE, HU, NL, PL, RS, UK, US, ZA) over 6 months 
  • Smart screening pathway with localized, county-specific landing pages and outreach aligned with each patient population’s demographics, supporting two parallel protocols 

Our results:

What do our patients say?

Metabolic disorder FAQs

Why do age-specific recruitment strategies matter in metabolic disorder clinical trials?

Metabolic disorders affect patients across all age groups, but recruitment approaches must reflect the needs of each population. Younger adults may be more responsive to digital and social media recruitment, while older adults often have multiple comorbidities, polypharmacy, mobility considerations, or caregiver involvement that can influence study participation. Communication preferences, health literacy, and motivations for joining clinical research also vary by age. Clariness tailors recruitment campaigns, patient communications, and engagement strategies to each study population, helping sponsors reach eligible participants while improving referral quality and patient experience. 

Metabolic disorder clinical trials, such as obesity and diabetes, have strict I/E criteria that require participants with specific medication histories, lifestyle characteristics, and comorbidities. Despite the high prevalence of these conditions, these requirements may often result in high screen failure rates. Clariness addresses these challenges through protocol-specific pre-screening, targeted patient recruitment, and close collaboration with study sites to identify participants who are most likely to qualify before referral. 

Many people living with obesity have experienced stigma or bias in healthcare, making respectful, empathetic communication essential for successful recruitment. Clariness develops patient-friendly campaigns through our Creatives team, using inclusive language, relatable imagery, and educational materials that encourage participation while reducing stigma. 

Lifestyle factors are often a key component of metabolic disorder clinical trial eligibility. Criteria related to diet, exercise, weight history, alcohol use, previous weight-loss programs, treatment history, and metabolic comorbidities can make recruitment particularly complex. Clariness incorporates these protocol-specific requirements into its recruitment and pre-screening approach, helping identify better-qualified participants before referral. 

Many obesity and diabetes clinical trials involve long-term participation, regular monitoring, lifestyle interventions, and frequent assessments of weight, diet, physical activity, or metabolic health. Combined with the stigma often associated with these conditions, maintaining patient motivation can be challenging. Clariness develops patient-centric educational materials and empathetic communication that build trust, set realistic expectations, and support participants from recruitment through study completion. 

Related insights

How much is delayed metabolic disorder enrollment costing you? ​

Stand out in a crowded metabolic disorder landscape with a strategy that starts with robust feasibility insights, builds awareness through effective clinical trial branding, and drives a stronger patient recruitment pipeline.